Report cover image

Ophthalmic Drugs Market Size, Share, By Product Type (Prescription Drugs and Over The Counter Drugs), Drug Type (Branded Drugs and Generic Drugs), Disease Indication (Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders, and Others), Route of Admi

Published Mar 01, 2024
Length 178 Pages
SKU # PRMI20148228

Description

Ophthalmic Drugs Market Size, Share, By Product Type (Prescription Drugs and Over The Counter Drugs), Drug Type (Branded Drugs and Generic Drugs), Disease Indication (Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders, and Others), Route of Administration (Topical, Local Ocular, and Systemic), Dosage Form (Gels, Eye Solutions and Suspension, Capsules and Tablets, Eye Drops, and Others), Therapeutic Class (Anti-inflammatory Drugs, Anti-infective Drugs, Anti-glaucoma Drugs, Anti-allergy Drugs, Anti-VEGF Agents, and Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Independent Pharmacies and Others), and Region - Trends, Analysis, and Forecast till 2035

The Ophthalmic Drugs Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.

Ophthalmic drugs are medicinal products designed to treat eye disorders such as glaucoma, infections, dry eyes, and inflammation. The ophthalmic drugs market growth is driven by increasing prevalence of eye diseases, aging population, and healthcare spending. Innovations in sustained release, gene therapy, and targeted drug delivery aim to reduce treatment burden and potentially curative treatments for various eye diseases.

Report Highlights:

Ophthalmic drugs market size is accounted at USD 41.2 Billion in 2025.

Target market size is expected to develop at a rate of USD 64.5 Billion by 2035 and at a CAGR of 5.0%.

According to product type, the prescription drugs is the product type dominating the ophthalmic drugs market share.

On the basis of drug type, the branded ophthalmic drugs are expected to lead the target market.

Stemming from disease indication, the retinal disorders segment is ruling over the ophthalmic drugs market.

Under route of administration, the topical route of administration is attributed to govern the ophthalmic drugs market.

Dependent on dosage form, the eye drops segment is holding the superior position in the ophthalmic drugs market.

According to therapeutic class, the anti-VEGF agents is holding the upper hand in the ophthalmic drugs market.

Appertaining from distribution channel, the hospital pharmacies is anticipated to influence the ophthalmic drugs market.

By region, North America is the region which has the largest ophthalmic drugs market share.

Europe is the region which has the fastest growing ophthalmic drugs market, during the forecast period.

Key Highlights:
  • In January 2024, Amneal Pharmaceuticals, Inc. announced the approval and launch of fluorometholone ophthalmic suspension. The product received 180-day competitive generic therapy (CGT) exclusivity from the U.S. Food and Drug Administration, a status that applies to first-marketed generics of key medicines.
Report Analysis:

Measures to increase eye drop absorption:
  • Waiting for 5?10 minutes between drops.
  • Compressing lacrimal sac.
  • Keeping lids closed for 5 minutes after instillation.
  • 50% drug remains 4 minutes after instillation.
  • 10% drug reach aqueous humour.
  • Compressing NLD (Nasolacrimal Duct) to decrease systemic absorption.
Segmentation:

By Product Type:
  • Prescription Drugs
  • Over The Counter Drugs
By Drug Type:
  • Branded Drugs
  • Generic Drugs
By Disease Indication:
  • Dry Eye
  • Glaucoma
  • Infection/Inflammation
  • Retinal Disorders
  • Others
By Route of Administration:
  • Topical
  • Local Ocular
  • Systemic
By Dosage Form:
  • Gels
  • Eye Solutions & Suspensions
  • Capsules and Tablets
  • Eye Drops
  • Ointments
  • Others
By Therapeutic Class:
  • Anti-inflammatory Drugs
  • Anti-infective Drugs
  • Anti-glaucoma Drugs
  • Anti-allergy Drugs
  • Anti-VEGF Agents
  • Others
By Distribution Channel:
  • Hospital Pharmacies
  • Online Pharmacies
  • Independent Pharmacies
  • Others
By Region:
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa
Ophthalmic Drugs Market Companies:

Alcon Inc.

Bausch + Lomb

Pfizer Inc.

F. Hoffmann-La Roche Ltd

Grevis Pharmaceuticals Pvt Ltd.

Eyeris Vision Care Pvt. Ltd.

Santen Pharmaceutical Co., Ltd.

Genentech USA, Inc.

Sun Pharmaceutical Industries, Inc.

Coherus BioSciences, Inc.

Johnson & Johnson

Teva Pharmaceutical Industries Ltd.

Harrow

Ocular Therapeutix, Inc.

EyePoint Pharmaceuticals, Inc.

What Our Report Offers:
  • Regional & Country-Specific Market Intelligence: Gain a competitive edge with in-depth market share breakdowns across critical regions and nations, helping you identify growth opportunities and strategic positioning.
  • Strategic Entry Support for New Entrants: Expert-backed recommendations to navigate market entry challenges, establish a strong presence, and accelerate growth in unfamiliar markets.
  • Accurate Long-Term Market Projections: Trusted forecasts spanning 2025 to 2035, including key milestones for 2025, 2026, and 2030, empowering data-driven decision-making for sustainable investments.
  • Comprehensive Market Trend Analysis: A deep dive into market drivers, barriers, emerging opportunities, and potential risks, alongside insights into high-growth investment areas and industry challenges.
  • Actionable Business Strategies: Data-powered recommendations customized for key market segments, supported by rigorous market assessments to maximize profitability.
  • Competitive Landscape Mapping: Uncover prevailing industry trends, competitor tactics, and untapped opportunities to refine your market approach and stay ahead.
  • Exclusive Company Profiles: Detailed evaluations of leading market players, covering business models, financial health, strategic moves, and recent advancements.
  • Next-Gen Supply Chain Trends: Cutting-edge insights into technological innovations revolutionizing supply chain operations, enhancing efficiency, and reducing costs.
This report equips you with the intelligence needed to make informed, forward-thinking business decisions in a rapidly evolving market landscape.

FAQs:

Key Questions Answered in the Report.

1. What was the Ophthalmic Drugs Market size in 2025?

2. What is projected growth rate of the Ophthalmic Drugs Market during 2025-2035?

3. What are the key factors driving the Ophthalmic Drugs Market growth?

4. What are leading players in the Ophthalmic Drugs Market?

5. What are the key regions analyzed in the Ophthalmic Drugs Market?

6. Which region is dominating in the Ophthalmic Drugs Market?

Table of Contents

178 Pages
Global Opthalmic Drugs Market Table of Contents
Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
Market Preview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Drug Type
Market Snippet, By Disease Indication
Market Snippet, By Route of Administration
Market Snippet, By Dosage Form
Market Snippet, By Therapeutic Class
Market Snippet, By Distribution Channel
Market Snippet, By Region
Opportunity Map Analysis
Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Market Trends
Type Launch
Merger and Acquisitions
Impact Analysis
PEST Analysis
Porter’s Analysis
Adverse Reactions of Ophthalmic Drugs
New Product Launches
Mergers and Acquisitions
Market Segmentation, By Product Type, Forecast Period up to 10 Years, (USD Bn)
Overview
Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Prescription Drugs
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Over The Counter Drugs
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By Type, Forecast Period up to 10 Years, (USD Bn)
Overview
Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Branded Drugs
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Generic Drugs
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By Disease Indication, Forecast Period up to 10 Years, (USD Bn)
Overview
Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Dry Eye
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Glaucoma
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Infection/Inflammation
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Retinal Disorders
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Others
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By Route of Administration, Forecast Period up to 10 Years, (USD Bn)
Overview
Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Topical
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Local Ocular
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Systemic
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By Dosage Form, Forecast Period up to 10 Years, (USD Bn)
Overview
Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Gels
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Eye Solutions and Suspensions
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Capsules and Tablets
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Eye Drops
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Others
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By Therapeutic Class, Forecast Period up to 10 Years, (USD Bn)
Overview
Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Anti-Inflammatory Drugs
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Anti-Infective Drugs
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Anti-Glaucoma Drugs
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Anti-Allergy Drugs
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Anti-VEGF Agents
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Others
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By Distribution Channel, Forecast Period up to 10 Years, (USD Bn)
Overview
Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Segment Trends
Hospital Pharmacies
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Online Pharmacies
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Independent Pharmacies
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Others
Overview
Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)
Overview
Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
Regional Trends
North America
Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Drug Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Disease Indication, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Dosage Form, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Therapeutic Class, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
U.S.
Canada
Asia Pacific
Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Drug Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Disease Indication, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Dosage Form, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Therapeutic Class, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
China
India
Japan
Australia
Indonesia
Malaysia
South Korea
Rest of Asia Pacific
Europe
Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Drug Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Disease Indication, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Dosage Form, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Therapeutic Class, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
Germany
U.K.
France
Russia
Italy
Spain
Netherlands
Rest of Europe
Latin America
Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Drug Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Disease Indication, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Dosage Form, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Therapeutic Class, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
Brazil
Mexico
Argentina
Rest of Latin America
Middle East and Africa
Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Drug Type, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Disease Indication, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Route of Administration, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Dosage Form, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Therapeutic Class, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years
Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
GCC
Israel
South Africa
Rest of Middle East & Africa
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.